-
Hereditary Angioedema Drug Market Expansion Forecasted at X% CAGR to X Billion USD by 2032 | Argenx, Shire ,CSL Behring
31 Jan 2025 08:08 GMT
… Include:
BioCryst Pharmaceuticals
Takeda Pharmaceutical Company Limited
Ionis Pharmaceuticals
argenx
Shire
CSL Behring …
Zealand Pharma A/S
Roche
Alnylam Pharmaceuticals …
-
Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval
07 Feb 2025 00:23 GMT
… patients in Japan. This JCR Pharmaceuticals drug, marketed as Izcargo, also … came from its acquisition of Shire.
At the WORLDSymposium, JCR presented …
-
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer
16 Dec 2024 13:00 GMT
… increasing responsibility at Takeda Pharmaceuticals (formerly Shire), most recently serving as … common stock under the Crinetics Pharmaceuticals, Inc. 2021 Employment … c)(4). ABOUT CRINETICS PHARMACEUTICALS
Crinetics Pharmaceuticals is a clinical stage …
-
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
15 Oct 2024 10:00 GMT
… Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer … by his co-founding of Shire Pharmaceuticals. He brings a wealth of …
-
Thetis Pharmaceuticals Announces Appointment of Fabio Cataldi, M.D., to Board of Managers and Scientific Advisory Board
14 Nov 2024 12:10 GMT
Thetis Pharmaceuticals, LLC (“Thetis”), a pharmaceutical company … &D roles at Arena Pharmaceuticals, AbbVie, Shire, Pfizer, Biogen, and Novartis … these difficult diseases.”
About Thetis Pharmaceuticals
Thetis is a clinical-stage …
-
Companies Vie to Develop a Hunter Syndrome Therapy That Reaches the Brain
03 Feb 2025 06:34 GMT
… replacement therapy (Elaprase), produced by Shire Pharmaceuticals, have been approved for use … frontrunner among these contenders, JCR Pharmaceuticals, is working on JR-141 …
-
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
28 Oct 2024 10:23 GMT
… , including Currax Pharmaceuticals, Horizon Therapeutics, Graceway Pharmaceuticals, and Medicis, … Karyopharm Therapeutics, Servier (previously Shire/Baxalta/Baxter), … com. About Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. is a specialty …
-
Christophe Weber, veteran Takeda CEO, to retire next year
30 Jan 2025 17:49 GMT
… , some questioned whether the Shire deal was worth the cost … ’s Emma Walmsley, Vertex Pharmaceuticals’ Reshma Kewalramani and Merck KGaA … takeover by Shire. Her last position at Shire was global … franchise head for hematology before Shire’s takeover by Takeda. …
-
Takeda CEO succession confirmed as Weber plans retirement
30 Jan 2025 11:22 GMT
Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.
Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese …
-
STAT+: Takeda CEO Christophe Weber to step down following prolonged drop in company shares
30 Jan 2025 15:04 GMT
… its $62 billion acquisition of Shire Pharmaceuticals in 2019. He will be … held several executive roles at Shire and joined Takeda through the …
About
© 1995-2025